Renovo News
-
29th April 2010Renovo will announce its interim results for the 6 months to 31 March 2010 at 7:00am on Thursday 20 May 2010....read more
-
29th March 2010Details of today's press release announcing that the first pivotal Phase III trial for Juvista in scar revision is now fully recruited can be viewed ...read more
-
2nd March 2010Details of the RNS detailing the revised Shire licensing deal for Juvista can be viewed here...read more
-
20th January 2010Renovo is one of three presenters updating investors at this evening presentation. Registration available via www.proactiveinvestors.co.uk...read more
-
5th January 2010An HTML version of our 2009 Annual Report is available at http://ar09.renovoreports.com...read more
-
17th November 2009Dr Sharon O'Kane Wins Award...read more
-
17th November 2009Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing, will announce its preliminary results for the year ended 30 September 2009 at 7.00am on Tuesday 15 December 2009. ...read more